| Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels U Akcan, S Karabulut, Cİ Küçükali, S Çakır, E Tüzün Acta neuropsychiatrica 30 (2), 70-78, 2018 | 36 | 2018 |
| Expression changes of genes associated with apoptosis and survival processes in Parkinson’s disease N Yalçınkaya, H Haytural, B Bilgiç, Ö Özdemir, H Hanağası, Cİ Küçükali, ... Neuroscience letters 615, 72-77, 2016 | 35 | 2016 |
| Targeted delivery of lacosamide-conjugated gold nanoparticles into the brain in temporal lobe epilepsy in rats CU Yilmaz, S Emik, N Orhan, A Temizyurek, M Atis, U Akcan, ... Life Sciences 257, 118081, 2020 | 22 | 2020 |
| Inflammation and neurodegeneration in patients with early-stageand chronic bipolar disorder S Karabulut, I Taşdemir, U Akcan, CI Küçükali, E Tüzün, S Cakir Turk Psikiyatri Dergisi 30 (2), 75, 2019 | 20 | 2019 |
| Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis F Esen, G Orhun, PE Ozcan, E Senturk, M Kucukerden, M Giris, U Akcan, ... Intensive care medicine experimental 5, 1-12, 2017 | 20 | 2017 |
| Effects of methyl-beta-cyclodextrin on blood-brain barrier permeability in angiotensin II-induced hypertensive rats M Atış, U Akcan, CU Yılmaz, N Orhan, P Düzgün, UD Ceylan, N Arıcan, ... Brain Research 1715, 148-155, 2019 | 13 | 2019 |
| Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo A Kayabolen, U Akcan, D Özturan, H Ulbegi‐Polat, GN Sahin, ... Advanced Science 9 (27), 2201294, 2022 | 10 | 2022 |
| Serum prolactin levels in multiple sclerosis, neuromyelitis optica, and clinically isolated syndrome patients R Türkoğlu, M Gencer, U Akcan, A Örçen Nöro Psikiyatri Arşivi 53 (4), 353, 2016 | 10 | 2016 |
| Reduced fecal GABA levels in multiple sclerosis patients N Yalçınkaya, U Akcan, A Örçen, Cİ Küçükali, R Türkoğlu, M Kürtüncü, ... Multiple Sclerosis and Related Disorders 9, 60-61, 2016 | 7 | 2016 |
| Blood-brain barrier targeted delivery of lacosamide-conjugated gold nanoparticles: Improving outcomes in absence seizures A Temizyürek, CU Yılmaz, S Emik, U Akcan, M Atış, N Orhan, N Arıcan, ... Epilepsy Research 184, 106939, 2022 | 6 | 2022 |
| Erken evre ve kronik bipolar bozukluk hastalarında inflamasyon ve nörodejenerasyon bulguları S Karabulut, İ Taşdemir, U Akcan, Cİ Küçükali, E Tüzün, S Çakır Turk Psikiyatri Derg 30, 75-81, 2019 | 6 | 2019 |
| Reduced peripheral blood mononuclear cell ROCK1 and ROCK2 levels in obstructive sleep apnea syndrome Ş Aydin, C Özdemir, CI Küçükali, SN Sökücü, M GIRIŞ, U AKCAN, ... in vivo 32 (2), 319-325, 2018 | 5 | 2018 |
| Tissue distribution and cellular localization of gold nanocarriers with bound oligonucleotides N Fatima, U Akcan, M Kaya, R Gromnicova, J Loughlin, B Sharrack, ... Nanomedicine 16 (9), 709-720, 2021 | 4 | 2021 |
| Targeting the blood–brain barrier disruption in hypertension by ALK5/TGF-Β type I receptor inhibitor SB-431542 and dynamin inhibitor dynasore M Atis, U Akcan, D Altunsu, E Ayvaz, CU Yılmaz, D Sarıkaya, ... Brain Research 1794, 148071, 2022 | 3 | 2022 |
| Abstracts from the 20th international symposium on signal transduction at the blood-brain barriers A Małecki, J Skipor-Lahuta, M Toborek, NJ Abbott, DA Antonetti, EJ Su, ... Fluids and Barriers of the CNS 14, 1-23, 2017 | 2 | 2017 |
| Inflammation and neurodegeneration findings in early stage bipolar disorder S Karabulut, U Akcan, İC Küçükali, E Tüzün, S Çakır European Psychiatry 41 (S1), S75-S76, 2017 | 1 | 2017 |
| Viability of SH-SY5Y cells is associated with purinergic P2 receptor expression alterations AA Örçen, V Yilmaz, U Akcan, E Tüzün, G Erten Acta Biologica Hungarica 68 (1), 22-34, 2017 | 1 | 2017 |
| IgG-conjugated Gold Nanoparticles Restore Blood-Brain Barrier Damage in Both in vitro and in vivo Models of Sepsis F Esen, U Akcan, O Cavuslar, G Orhun, PE Ozcan, HY Acar, A Temizyurek, ... ACTA PHYSIOLOGICA 234, 64-64, 2022 | | 2022 |
| The Effects of Histamine Receptor Antagonists and RhoA Inhibitor on Histamine-Induced Blood-Brain Barrier Disruption U Akcan, A Temizyurek, D Ozen, FS Polat, CU Yilmaz, G Demirci, ... ACTA PHYSIOLOGICA 234, 32-32, 2022 | | 2022 |
| Protein scaffold-based multimerization of soluble ACE2 efficiently blocks SARS-CoV-2 infection in vitro (preprint) A Kayabolen, U Akcan, D Ozturan, E Sarayloo, E Nurtop, B Ozer, ... | | 2021 |
